Mechanisms of immune complex-mediated experimental glomerulonephritis: Possible role of the balance between endogenous TNF and soluble TNF receptor type 2

European Cytokine Network

Volumn 23, Issue 1, 2012, Pages 15-20

  Pfeifer, Eva ^a   Polz, Johannes ^a   Grießl, Sybille ^a   Mostböck, Sven ^a   Hehlgans, Thomas ^a   Männel, Daniela N ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Inflammation; Kidney; P75TNF receptor; TNFR2; Tolerance; Tumor necrosis factor

Indexed keywords

COMPLEMENTARY DNA; CREATININE; CYTOKINE; ENDOTOXIN; GENOMIC DNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; IMMUNE COMPLEX NEPHRITIS; IMMUNE SYSTEM; INFLAMMATION; KIDNEY FUNCTION; MORTALITY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEINURIA; TRANSGENIC MOUSE; URINARY EXCRETION; URINE LEVEL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES; ANTIGEN-ANTIBODY COMPLEX; CREATININE; GLOMERULAR BASEMENT MEMBRANE; GLOMERULONEPHRITIS; HUMANS; KIDNEY; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEINURIA; RABBITS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); MUS;

EID: 84859358893     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2012.0299     Document Type: Article

References (16)

1. Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005; 115: 1-20.
2. Vielhauer V, Mayadas TN. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol 2007; 27: 286-308.
3. Sanchez-Nino MD, Benito-Martin A, Goncalves S, Sanz AB, Ucero AC, Izquierdo MC, et al. TNF superfamily: a growing saga of kidney injury modulators. Mediators Inflamm 2010; pii: 182958. Epub 2010 Oct 4.
4. Vielhauer V, Stavrakis G, Mayadas TN. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest 2005; 115: 1199-209.
5. Assmann KJ, Tangelder MM, Lange WP, Schrijver G, Koene RA. Anti-GBM nephritis in the mouse: severe proteinuria in the heterologous phase. Virchows Arch A Pathol Anat Histopathol 1985; 406: 285-99.
6. Erickson SL, de Sauvage FJ, Kikly K, et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994; 372: 560-3.
7. Schorpp M, Jager R, Schellander K, et al. The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res 1996; 24: 1787-8.
8. Bäumel M, Lechner A, Hehlgans T, Männel DN. Enhanced susceptibility to Con A-induced liver injury in mice transgenic for the intracellular isoform of human TNF receptor type 2. J Leukoc Biol 2008; 84: 162-9.
9. Chen X, Bäumel M, Männel DN, Howard OM, Oppenheim JJ. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol 2007; 179: 154-61.
10. Chen X, Subleski JJ, Kopf H, Howard OM, Männel DN, Oppenheim JJ. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J Immunol 2008; 180: 6467-71.
11. Zingarelli B, Makhalouf M, Halushka P, Caputi A, Cook J. Altered macrophage function in tumor necrosis factor alpha- and endotoxininduced tolerance. J Endotoxin Res 1995 2, 247-54.
12. Ferlito M, Romanenko OG, Ashton S, Squadrito F, Halushka PV, Cook JA. Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production. J Leukoc Biol 2001; 70: 821-9.
13. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009; 30: 475-87.
14. Kollias G, Kontoyiannis D. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev 2002; 13: 315-21.
15. Isomaki P, Panesar M, Annenkov A, et al. Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface. J Immunol 2001; 166: 5495-507.
16. Liu S, Rong L, Deng J, et al. TNFR2 expression on non-bone marrow-derived cells is crucial for lipopolysaccharide-induced septic shock and downregulation of soluble TNFR2 level in serum. Cell Mol Immunol 2011; 8: 164-71.